Dr. Gilgun-Sherki has more than 20 years of experience in academic research and the pharmaceutical industry. Some of his previous positions include Head of Specialty Products at Dexcel Pharma and Global Clinical Program Leader & Senior Clinical Scientist at Teva Global Innovative R&D group.
Yossi previously served as an investigator and coordinator in clinical trials conducted at the Neurology Department, Rabin Medical Center.
He is a (co)author of over 40 publications and book chapters, and an inventor of 6 patents in the field of neurodegeneration.
PhD in Neuropharmacology from Tel Aviv University. MBA from The Open University, Israel